Most Recent
October 30, 2025
At the World Network conference, I showed how World ID's 15M verified users can integrate with GenoBank.io's Biowallet - the world's first Decentralized Laboratory ID - to own biosamples, license genomic data for research revenue, recover lost credentials via DNA, and pass tokenized assets to children. GenoBank.io already has the infrastructure; World ID adds proof-of-personhood verification.
Read MoreOctober 28, 2025
Nucleus Genomics, DNA Complete, Sequencing.com, Color Health, and others offer affordable whole genome sequencing—but none provide blockchain-based ownership notarization. In the AI era, consumers paying $195-$500 for sequencing must demand privacy and property rights, or risk becoming '23andMe's waiting to happen.'
Read MoreOctober 27, 2025
How genomics startups can build $50M+ businesses while ensuring contributors become partners, not just data sources. Lessons from Basepaws, 23andMe, and the emerging BioIP framework.
Read MoreOctober 26, 2025
Proposal for Dr. Rachel Karchin & Dr. Jasmine Plummer: Transform OpenCRAVAT into the world's first decentralized blockchain for genomic variant annotation, combining Karchin Lab's scientific leadership with GenoBank.io BioFS, Story Protocol, and Claude AI integration.
Read MoreOctober 23, 2025
A groundbreaking 2025 IEEE research paper reveals that LLM systems face three critical categories of privacy risks that traditional security measures cannot address. For genomics, where data is protected under GDPR Article 9, these risks are existential. Here's how GenoBank.io's BioFS architecture solves all three.
Read MoreOctober 22, 2025
While data breaches dominate headlines, the real revolution is transforming genomic security risks into licensable intellectual property. Here's how BioFS + Claude + Story Protocol turn genetic analysis into revenue-generating BioIP assets.
Read MoreOctober 21, 2025
A comprehensive technical whitepaper exploring the complete metamorphosis journey of biosamples through GenoBank's ecosystem—from DNA kit activation to tokenized genomic intelligence. Featuring BioNFT V2 architecture with native alphanumeric biosample ID support.
Read MoreOctober 20, 2025
How BioFS's sandboxed architecture provides the secure, GDPR-compliant foundation that Claude for Life Sciences needs to process sensitive genomic data safely.
Read MoreOctober 16, 2025
A comprehensive technical whitepaper comparing BioNFS to traditional Storage Area Networks (SAN), explaining BioNFTs as Decentralized Access Control Lists, and documenting the five-phase metamorphosis of biosamples through GenoBank's microservices ecosystem.
Read MoreOctober 14, 2025
As AI models like Evo 2 generate novel bacteriophage genomes, BioNFTs provide the critical infrastructure for accountability, traceability, and regulatory compliance in synthetic biology.
Read MoreOctober 5, 2025
A technical overview of BioFS CLI tool showing how Story Protocol's Programmable IP Licenses enable secure genomic data sharing with blockchain verification.
Read MoreOctober 3, 2025
Congratulations to NIH's BEACONS initiative! Now let's talk about what truly informed consent requires in 2025: disclosing blockchain ownership options and AI training use to parents.
Read MoreSeptember 26, 2025
GenoBank.io blog post
Read MoreSeptember 19, 2025
Discover how patients can transform their genomic data into yield-generating assets while contributing to medical breakthroughs through the revolutionary BioIPFi platform combining GenoBank, Verio, and Story Protocol.
Read MoreSeptember 19, 2025
A comprehensive white paper on GenoBank's Web3 implementation of OpenCRAVAT, enabling decentralized variant annotation with NFT tokenization and Web3 authentication.
Read MoreSeptember 18, 2025
As AI models like Evo2 create functional genomes with hundreds of novel mutations, blockchain-based SynBioNFTs emerge as essential infrastructure for ensuring ownership, safety, and regulatory compliance in the age of programmable life.
Read MoreSeptember 18, 2025
How GenoBank's BioNFT-gated S3 streaming service solves the trillion-cell hyperspectral imaging data challenge with hybrid hot/cold storage and sub-second access.
Read MoreAugust 18, 2025
Baby KJ's breakthrough gene therapy for CPS1 deficiency took months to develop. With GenoBank's Web3-enabled platform, Story Protocol, and AI-powered transparency, the next baby could be treated in days, not months.
Read MoreJanuary 24, 2025
GenoBank.io is redefining personal genomics through its Bio Data Vault and AI-Family Health Vault, enabling individuals and families to securely own, manage, and share their genetic data while advancing personalized medicine.
Read MoreJuly 24, 2021
Conforme la pandemia ha avanzado y hemos rebasado distintas metas para lograr un desempeño mucho más efectivo, se ha mostrado ciertas fallas en nuestros sistemas de seguridad sanitaria. De lo que estoy hablando es nada más y nada menos que de las pruebas de COVID-19 falsificadas.
Read MoreJuly 23, 2021
Daniel Uribe the co-founder and CEO of GenoBank.io was invited to discuss his work at The
Read MoreJuly 23, 2021
GenoBank.io and the government of the State of Quintana Roo will now be working together using the Avalanche platform to verify the authenticity of COVID-19 results to combat test fraud.
Read MoreJune 24, 2021
GenoBank.io is proud to announce a partnership with NiMEDix, a Nigerian based blockchain/AI company looking to bridging the gap in remittances, promoting collaboration and partnerships, diversification of healthcare funding and creating access to healthcare services.
Read MoreJune 6, 2021
This weekend, California just announced a new initiative to allow residents to digitize their COVID-19 vaccine records. This article reviews this initiative, the underlying technology and how it affects you.
Read MoreJune 3, 2021
GenoBank.io is proud to announce a partnership with Bustamante Lab, a new research and development laboratory in Hialeah
Read MoreMay 28, 2021
GenoBank.io is partnering with Comed.mx and a network of laboratories based in Mexico City, Mexico. Both companies are tackling concerns raised over fake Covid tests and lack of standardized controls.
Read MoreMay 23, 2021
In just a matter of weeks we’ve been able to supply 2,000 COVID-19 tests per week on the blockchain and are anticipating growth in the next coming months.
Read MoreMarch 18, 2021
5 reasons how GenoBank.io helps prevent with future hacks
Read MoreMarch 11, 2021
Daniel es un emprendedor serial, especialista en ciberseguridad e inversor ángel en blockchain. Es exalumno de Stanford y Singularity University.
Read MoreMarch 11, 2021
Tim, Bill, and Polly Draper are back to find investment-worthy companies. Special guest include judges: Naveen Jain, founder and CEO of Viome and Grant Cardone.
Read MoreFebruary 24, 2021
How we can deliver safe and authentic vaccines, and allow patients to lead normal lives when they are immune to
Read MoreFebruary 1, 2021
GenoBank.io — who claim they are the first-ever anonymous, privacy-preserving DNA extraction kit — has reached $418,000 in crowdfunding from over 1,400 investors around the world
Read MoreJanuary 30, 2021
Our mission is to secure EOSIO blockchains with reliable infrastructure and to build a global community empowered with the tools and resources to thrive. We’re committed to leading and contributing to projects that add value to the ecosystem.
Read MoreJanuary 29, 2021
Welcome to the future of biospecimen decentralized ownership and governance using non-fungible-tokens (NFTs) based on
Read MoreJanuary 28, 2021
Incognito and encrypted DNA extraction kit brand, GenoBank.io, has successfully raised nearly $435,000 in funding through its crowdfunding round on Republic.
Read MoreJanuary 28, 2021
Please join our beta technology preview on how GenoBank.io enables users establish ownership and control over their
Read MoreJanuary 28, 2021
Block.one, the company behind EOSIO (EOS), issued a $50,000 grant to GenoBank.io for its open-source app on April 29
Read MoreJanuary 28, 2021
My motivation for founding GenoBank.io is much more than creating a sustainable business. GenoBank.io is mission driven, with our aim being to provide humanity with access to and control over their DNA.
Read MoreJanuary 28, 2021
CEO Daniel Uribe message for investors Republic.co/genobank-io Crowdfunding Campaign 2020
Read MoreJanuary 28, 2021
The company behind EOSIO, Block.one invests $50,000 grant as the GenoBank.io announced at the start of this month saying that the app, Agerona
Read MoreNovember 20, 2020
This document is a sample agreement that GenoBank.io and a laboratory/biobank
Read MoreOctober 29, 2020
A new model for tracking permissions using established blockchain standards, and an application for biosample data, is introduced.
Read MoreOctober 28, 2020
A new model for tracking permissions using established blockchain standards, and an application for biosample data, is introduced.
Read MoreOctober 28, 2020
The battle of legitimate authority and control over genomicsdata introduces a substantial legal andcomputational burden on data privacy.
Read More